AG
Dr. Agarwal's Health Care Limited
AGARWALEYE.NS · NSE
₹504.00 +0.39% (+₹1.95)
1M +0.09%
Market Cap ₹158.2B
P/E Ratio 106.62x
Div. Yield -
ROE 7.33%
Piotroski F-Score Strong
7/9Valuation
4 /100
Expensive EV/EBITDA 24.83x
P/S 7.17x
P/B 7.46x
Growth
75 /100
Growing Rev. growth 35.01%
FCF growth 37.59%
Book val. growth 106.37%
Profitability
50 /100
Moderate Net margin 6.72%
Op. margin 14.53%
FCF margin 2.24%
Quality
32 /100
Poor ROE 7.33%
ROA N/A
Asset turnover N/A
Debt
88 /100
Low Int. coverage 3.88x
Net debt/EBITDA 0.00x
Debt/Equity 0.00x
Stability
65 /100
Moderate Rev. volatility 9.59%
EPS volatility 88.75%
Profitable years 4
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre AGARWALEYE.NS
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Adil Agarwal
Employees
4,214
Headquarters
Chennai
Evenimente viitoare
29 OCT.
Earnings
Upcoming earnings report